At the gene level, hypermethylation of the promoter for C9orf72, a gene responsible for the majority of the FALS cases (as well as for those of frontotemporal dementia), correlates with its reduced mRNA expression levels in a clinical cohort of C9orf72 pathological expansion carriers [54]. Here, C9orf72 is linked to frontotemporal dementia.